On the other hand, an inverse relationship between IGF-1 circulating levels and incidence of metabolic syndrome (MetS) with liver steatosis, insulin resistance, hyperlipidemia and visceral obesity has been identified [10–13]. This evidence concerns the gene IGF1 and metabolic syndrome.